May 15 (Reuters)-
Enbio Holdings, Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2023 Mar 31, 2022 Mar 31, 2024 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 8.12 8.99 9.73
(-9.7 pct) (+31.4 pct) (+19.8 pct)
Operating 1.36 1.23 487 mln
(+10.4 pct) (+98.9 pct) (-64.1 pct)
Recurring 1.34 1.20 339 mln
(+12.1 pct) (+102.2 pct) (-74.8 pct)
Net
Net 812 mln 654 mln 201 mln
(+24.2 pct) (+115.1 pct) (-75.2 pct)
EPS 122.27 yen 98.52 yen 30.27 yen
EPS Diluted 98.47 yen
Ann Div 8.00 yen 8.00 yen 8.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 8.00 yen 8.00 yen 8.00 yen
NOTE - Enbio Holdings, Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6092.T